Go back

Political Corner: By leaving the INF Treaty, the US is abandoning peace

Written by: Kelly Grounds, Peak Associate

1987 Cold-War era Intermediate-Range Nuclear Forces (INF) treaty. The announcement came after multiple accusations by US officials that Russia has repeatedly violated the treaty since its conception.

The INF was established in the 1970s when Russia began to replace their older intermediate-range SS-4 and SS-5 missiles with a new intermediate-range missile, the SS-20. These new missiles had a firing range of up to 5000 km, far enough to reach all of Europe and northern parts of Northern Canada.

With the impending new threat, the North Atlantic Treaty Organization (NATO) began to negotiate an arms freeze with Russia, eventually resulting in the INF treaty. This created a framework for both the US and Russia to start to permanently eliminate their more powerful long-range nuclear missiles. There was also a regulation committee put in place to monitor both parties’ compliance with the treaty.

Much of why the US is dropping from the INF is due to US national security advisor John Bolton. Bolton carries a less informed attitude of American global nuclear power, showing disinterest in any compromise with potential threats to the US. His dislike towards agreements like the INF are strong enough that even his memoir is titled Surrender is not an Option.

Leaving the INF is a continuation of a pattern for the US, as they appear unwilling to be in any deal that promotes international peace. They’ve already pulled out of the Anti-Ballistic Missile (ABM) treaty, and it seems the Obama-era New Start treaty could be at risk next.

Very quickly, President Trump’s advisors are dismantling arms control with their incredibly biased advice. Peace does not appear to be something the US is interested in maintaining.

Was this article helpful?
0
0

Leave a Reply

Block title

New immunotherapy treatment provides hope for aggressive cancer

By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Read Next

Block title

New immunotherapy treatment provides hope for aggressive cancer

By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Block title

New immunotherapy treatment provides hope for aggressive cancer

By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...